MOLN — Molecular Partners AG Balance Sheet
0.000.00%
Last trade - 00:00- CH₣127.96m
- -CH₣19.04m
- CH₣4.97m
Annual balance sheet for Molecular Partners AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 174 | 133 | 249 | 187 | 149 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.84 | 25.7 | 1.7 | 3.08 | 2.59 |
| Prepaid Expenses | |||||
| Total Current Assets | 178 | 164 | 255 | 192 | 154 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.39 | 8.15 | 7.24 | 5.68 | 4.2 |
| Net Intangible Assets | |||||
| Total Assets | 188 | 173 | 262 | 198 | 159 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 57.7 | 46.9 | 17.3 | 14.4 | 10.8 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 80.3 | 65.4 | 27.1 | 21.9 | 16.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 107 | 107 | 235 | 176 | 142 |
| Total Liabilities & Shareholders' Equity | 188 | 173 | 262 | 198 | 159 |
| Total Common Shares Outstanding |